Study guide

7.2 Central Nervous System Infections & Increased Intracranial Pressure

Pediatric Nursing Certification PED-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Blueprint & Clinical Decision-Making

1.1 ANCC PED-BC Exam Facts, Scoring & Test Blueprint 1.2 The Pediatric Nursing Process & Clinical Judgment Model 1.3 Prioritization, Clinical Case Analysis & Practice Strategies

2 Chapter 2: Pediatric Growth, Development & Milestones

2.1 Infancy and Toddlerhood: Physical Growth & Motor Milestones 2.2 Preschool, School-Age & Adolescent Milestones 2.3 Developmental Theories: Erikson, Piaget, Kohlberg & Freud

3 Chapter 3: Pediatric Physical Assessment, Vital Signs & Diagnostic Screening

3.1 Pediatric Physical Examination & Age-Specific Vital Sign Norms 3.2 Pediatric Pain Assessment Scales & Developmental Screening 3.3 Pediatric Laboratory Values & Diagnostic Specimen Collection

4 Chapter 4: Pediatric Fluid, Electrolyte & Nutritional Management

4.1 Dehydration Severity, Oral Rehydration Therapy & IV Deficit Replacement 4.2 Pediatric Electrolyte Disturbances: Sodium, Potassium & Calcium Imbalances 4.3 Infant Nutrition, Formula Preparation, Failure to Thrive & Deficiencies

5 Chapter 5: Pediatric Respiratory Emergencies & Chronic Pulmonary Conditions

5.1 Upper Airway Obstruction: Croup, Epiglottitis & Foreign Body Aspiration 5.2 Lower Airway Infections: Bronchiolitis (RSV) & Pediatric Pneumonia 5.3 Chronic Pulmonary Disorders: Pediatric Asthma & Cystic Fibrosis Management

6 Chapter 6: Pediatric Congenital & Acquired Cardiovascular Disorders

6.1 Acyanotic Congenital Heart Defects: Left-to-Right Shunts & Obstructive Lesions 6.2 Cyanotic Defects & Complex Anomalies: Tetralogy of Fallot, TGA & Hypercyanotic Spells 6.3 Acquired Pediatric Heart Disease: Kawasaki Disease, Rheumatic Fever & Heart Failure

7 Chapter 7: Pediatric Neurological & Neuromuscular Disorders

7.1 Pediatric Seizure Disorders: Febrile Seizures, Epilepsy & Status Epilepticus 7.2 Central Nervous System Infections & Increased Intracranial Pressure 7.3 Structural Anomalies & Neuromuscular Disorders: Hydrocephalus, VP Shunts, Spina Bifida & Cerebral Palsy

8 Chapter 8: Pediatric Gastrointestinal & Hepatic Conditions

8.1 Acute Surgical Conditions: Pyloric Stenosis, Intussusception & Appendicitis 8.2 Congenital & Structural GI Anomalies: Cleft Lip/Palate, TEF & Hirschsprung Disease 8.3 Chronic GI & Malabsorption: Pediatric GERD, Celiac Disease & Inflammatory Bowel Disease

9 Chapter 9: Pediatric Renal & Genitourinary Conditions

9.1 Pediatric Urinary Tract Infections, Vesicoureteral Reflux & Enuresis 9.2 Glomerular Disorders: Minimal Change Nephrotic Syndrome & Acute Post-Streptococcal Glomerulonephritis 9.3 Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

10 Chapter 10: Pediatric Hematologic & Oncologic Conditions

10.1 Pediatric Anemias & Sickle Cell Disease Crises 10.2 Pediatric Bleeding Disorders: Hemophilia A/B & Immune Thrombocytopenia 10.3 Pediatric Leukemias, Solid Tumors & Oncologic Emergencies

11 Chapter 11: Pediatric Endocrine & Inborn Metabolic Disorders

11.1 Pediatric Type 1 Diabetes Mellitus & Diabetic Ketoacidosis Protocols 11.2 Pediatric Thyroid, Adrenal & Growth Hormone Disorders 11.3 Inborn Errors of Metabolism & Pubertal Disorders: PKU, Galactosemia & Precocious Puberty

12 Chapter 12: Pediatric Musculoskeletal, Integumentary & Infectious Disorders

12.1 Pediatric Orthopedics: Developmental Dysplasia of the Hip, Clubfoot, Scoliosis & Fractures 12.2 Pediatric Burns, Atopic Dermatitis & Dermatologic Conditions 12.3 Viral Exanthems, Communicable Diseases & Pediatric Sepsis Management

13 Chapter 13: Pediatric Pharmacology, Safe Dosage & Immunizations

13.1 Pediatric Pharmacokinetics, Weight-Based Calculations & Safe Dosing Limits 13.2 High-Alert Pediatric Medications, IV Infusion Safety & Vascular Access 13.3 CDC Childhood Immunization Schedules, Vaccine Safety & Catch-Up Guidelines

14 Chapter 14: Family-Centered Care, Psychosocial Health & Injury Prevention

14.1 Family-Centered Care Principles, Hospitalization Stress & Separation Anxiety 14.2 Developmentally Appropriate Procedural Preparation & Non-Pharmacological Comfort 14.3 Anticipatory Guidance, Car Seat Safety, Drowning & Poisoning Prevention

15 Chapter 15: Professional Role, Ethics, Legal Standards & Advocacy

15.1 Informed Consent, Minor Assent & Adolescent Confidentiality Rights 15.2 Mandatory Reporting: Identifying Child Abuse, Neglect & Human Trafficking 15.3 Evidence-Based Practice, Pediatric Quality Metrics & Interprofessional Collaboration

16 Chapter 16: Medication Reconciliation, Complementary Care & Interactions

16.1 Medication, Allergy & Treatment Reconciliation 16.2 Complementary Products & Treatment Interactions

17 Chapter 17: Individualized Assessment, Diversity & Psychosocial Safety

17.1 Culture, Resources, Religion & Individualized Care 17.2 Psychosocial Screening & Immediate Mental Health Safety

18 Chapter 18: Individualized Planning, Coordination & Family Teaching

18.1 Measurable Outcomes, Coordination & Delegation 18.2 Teach-Back, Return Demonstration & Learning Evaluation

19 Chapter 19: Patient Safety, Chronic Care & Outcome Evaluation

19.1 Withdrawal, Elopement, De-escalation & Risk Reduction 19.2 Chronic Care, Healthy Weight & Response Evaluation

7.2 Central Nervous System Infections & Increased Intracranial Pressure

Key Takeaways Explain This Topic AI

Acute bacterial meningitis pathogens vary by age: Group B Streptococcus, E. coli, and Listeria monocytogenes dominate in neonates; Streptococcus pneumoniae and Neisseria meningitidis predominate in infants and older children.

Infants with bacterial meningitis exhibit subtle, non-specific signs including bulging fontanelle, paradoxical irritability (crying worsens when held/rocked), and temperature instability, whereas older children display the classic triad of fever, severe headache, and nuchal rigidity.

Diagnostic lumbar puncture in bacterial meningitis reveals elevated opening pressure, turbid CSF, marked neutrophilic pleocytosis, elevated protein (>100–500 mg/dL), and markedly depressed glucose (<40 mg/dL or CSF:serum ratio <0.4).

Patients with suspected meningococcal disease require immediate Droplet Precautions maintained for at least 24 hours of effective IV antimicrobial therapy, and close contacts require chemoprophylaxis with oral rifampin, ceftriaxone, or ciprofloxacin.

Cushing's Triad (bradycardia, irregular respirations, and widened pulse pressure with systolic hypertension) is a late, life-threatening sign of impending brain herniation requiring emergency intervention including HOB elevation to 30 degrees midline and hyperosmolar therapy.

Last updated: October 2026

Central Nervous System Infections & Increased Intracranial Pressure

Quick Clinical Summary: Acute central nervous system (CNS) infections and intracranial hypertension represent time-critical pediatric neurological emergencies. Bacterial meningitis triggers intense subarachnoid purulent inflammation, cerebral vasculitis, and cerebral edema that can lead to permanent neurosensory loss, brain herniation, or death within hours. Pediatric nurses must rapidly interpret age-specific clinical manifestations—recognizing subtle paradoxical irritability in infants versus classic meningeal signs in older children—differentiate cerebrospinal fluid (CSF) profiles, initiate empirical antimicrobials with adjunctive dexamethasone, and enforce droplet precautions. Concurrently, managing increased intracranial pressure (ICP) hinges on the Monro-Kellie hypothesis , vigilance for late pre-herniation warnings ( Cushing's triad ), and rigid execution of midline positioning, normothermia, and hyperosmolar therapy.

1. Acute Bacterial Meningitis: Pathophysiology & Age-Specific Pathogens

Acute bacterial meningitis is a severe infectious inflammation of the meninges (arachnoid mater, pia mater, and intervening cerebrospinal fluid-filled subarachnoid space). Pathogens typically colonize the nasopharynx or respiratory epithelium, invade the bloodstream (bacteremia), breach the blood-brain barrier via receptor-mediated transcytosis, and multiply rapidly within the immunologically vulnerable subarachnoid space.

Bacterial lysis releases toxic cell wall fragments (endotoxin, lipopolysaccharides, peptidoglycans), triggering massive release of pro-inflammatory cytokines ( TNF-alpha, IL-1beta, IL-6 ). This induces:

Vasogenic Edema: Disruption of tight junctions in the cerebral capillary endothelium, flooding the interstitium with albumin and plasma.

Cytotoxic Edema: Intracellular accumulation of water and sodium within astrocytes and neurons secondary to cellular energy failure and toxic mediators.

Interstitial Edema: Blockage of CSF resorption at the arachnoid villi by purulent, viscous exudate, leading to non-communicating or communicating hydrocephalus.

Cerebral Vasculitis & Thrombosis: Inflammation of cortical vessels resulting in focal cerebral ischemia, infarction, and irreversible encephalomalacia.

Age-Stratified Microbiological Etiologies

The causative microorganisms of pediatric bacterial meningitis are strictly age-dependent: NEONATES (0 TO 28 DAYS):

  • * Group B Streptococcus (Streptococcus agalactiae) [Most common: ~50%]
  • * Escherichia coli (and other Gram-negative enteric bacilli, e.g., Klebsiella)
  • * Listeria monocytogenes

INFANTS & CHILDREN (1 MONTH TO ADOLESCENCE):

  • * Streptococcus pneumoniae (Pneumococcus) [Leading cause; high morbidity & hearing loss]
  • * Neisseria meningitidis (Meningococcus) [Epidemic potential; petechial/purpuric rash]
  • * Haemophilus influenzae type b (Hib) [Dramatically reduced in vaccinated populations]
  • 2. Clinical Manifestations: Infants vs. Older Children & Meningeal Signs

Clinical presentation differs fundamentally based on neurodevelopmental maturity and whether cranial fontanelles and sutures are open or closed.

Manifestations in Neonates & Young Infants (<1 Year)

In young infants, the classical signs of meningeal irritation are absent due to immature neuromotor reflexes and open fontanelles which accommodate expanding intracranial volume without acute nuchal rigidity. The presentation is notoriously subtle, non-specific, and insidious:

Paradoxical Irritability (Characteristic Behavioral Sign):

Important

Clinical Exam Pearl: In normal parental bonding, a crying, sick infant is comforted and soothed when picked up and rocked. In bacterial meningitis, the infant exhibits paradoxical irritability —crying intensely when held, rocked, or cuddled by parents, and calming only when left undisturbed lying flat in the crib. Rocking, flexing, and holding the infant stretches the inflamed spinal cord and meninges, causing acute agonizing pain.

Fontanelle Changes: Full, bulging, tense, or non-pulsatile anterior fontanelle (best examined when the infant is upright and quiet/not crying).

High-Pitched Piercing Cry: A shrill, inconsolable, sharp cry reflecting severe meningeal pain and intracranial irritation.

Feeding Patterns & Lethargy: Poor suck, refusal to feed, projectile vomiting, and extreme somnolence or difficult arousal.

Thermoregulatory Instability: While fever may occur, neonates frequently manifest hypothermia (temperature <36.0°C [96.8°F]), cold and clammy extremities, gray/mottled skin, and bradycardia or apnea.

Manifestations in Older Children & Adolescents

In children older than 1 to 2 years, presentation mirrors adult meningitis with the classic clinical triad :

  • Fever (acute, high-grade, often accompanied by rigors)
  • Severe, throbbing generalized headache (worsened by head motion, coughing, or light)
  • Altered mental status (confusion, irritability, delirium, lethargy progressing to stupor)
  • Clinical Examination of Meningeal Irritation

Nuchal Rigidity: Severe stiffness and resistance when the examiner attempts to passively flex the child's neck toward the chest. The child resists motion to avoid stretching the inflamed posterior cervical meninges.

Kernig's Sign: With the child lying supine, the examiner flexes the hip and knee to 90 degrees, and then attempts to extend the knee. A positive sign is elicited when passive knee extension is resisted or produces severe pain and hamstring spasm along the posterior thigh.

Brudzinski's Sign: With the child lying supine, the examiner passively flexes the neck toward the chest. A positive sign occurs when the child involuntarily flexes both hips and knees in response, demonstrating an involuntary reflex to relieve meningeal tension. KERNIG'S SIGN: Hip flexed 90 deg -> Attempt knee extension -> Resistance / Pain in hamstrings

  • BRUDZINSKI'S SIGN: Passive neck flexion -> Involuntary reflexive flexion of hips and knees
  • Petechial & Purpuric Rashes (Meningococcemia)

The development of a non-blanching petechial or purpuric rash in a febrile child is a catastrophic medical emergency indicating invasive meningococcal disease ( Neisseria meningitidis ) :

Lesions begin as small, discrete, erythematous maculopapules that rapidly transform within hours into non-blanching petechiae and coalescent, ecchymotic purpura ( purpura fulminans ).

Indicates widespread vascular endothelial necrosis, microvascular thrombosis, disseminated intravascular coagulation (DIC), severe septic shock, and bilateral adrenal hemorrhage ( Waterhouse-Friderichsen syndrome ).

3. Cerebrospinal Fluid (CSF) Analysis & Diagnostic Matrix

Definitive diagnosis requires a lumbar puncture (LP) , typically performed at the L3–L4 or L4–L5 vertebral interspace. Lumbar puncture must be immediately performed unless contraindicated by signs of impending brain herniation (focal neurological deficits, papilledema, Cushing's triad, pupillary asymmetry) or severe cardiopulmonary instability, in which case blood cultures must be drawn and empirical IV antibiotics administered immediately without waiting for imaging or LP.

Diagnostic Lumbar Puncture Profiles

CSF Diagnostic Parameter Normal Pediatric Range Acute Bacterial Meningitis Viral (Aseptic) Meningitis Fungal / Tuberculous Meningitis

Opening Pressure 50–180 mm H2O (infants: 10–100 mm H2O) Markedly Elevated (>200–300 mm H2O) Normal to Mildly Elevated (100–250 mm H2O) Significantly Elevated (>250–350 mm H2O)

Gross Appearance Crystal clear, colorless Turbid, cloudy, purulent , or milky Clear to slightly opalescent Clear, opalescent, or "cobweb/fibrin clot" formation

White Blood Cells (WBC) 0–5 cells/mcL (neonates: 0–30 cells/mcL) Markedly Elevated (1,000 to >10,000/mcL) Mildly Elevated (typically 50–500/mcL) Moderately Elevated (100–500/mcL)

Differential Monocytes / Lymphocytes (100%) Polymorphonuclear / Neutrophil Predominance (>80%) Lymphocytic Predominance (early 12–24h may show PMNs) Lymphocytic / Mononuclear Predominance

Protein Level 15–45 mg/dL (neonates: up to 100–150 mg/dL) Markedly Elevated (>100 to 500+ mg/dL) Normal to Mildly Elevated (50–100 mg/dL) Markedly Elevated (>100 to >500 mg/dL)

Glucose Level 45–80 mg/dL (or >60% of serum glucose) Markedly Decreased (<40 mg/dL) Normal (>45 mg/dL) Markedly Decreased (<30–40 mg/dL)

CSF / Serum Glucose Ratio 0.6 (60%) Depressed (<0.4 or <40%) , often <0.2 Normal (≥0.6 or ≥60%) Severely Depressed (<0.3 or <30%)

Microbiological Testing Negative Gram stain positive (60–90%) ; positive bacterial culture Gram stain negative; positive viral PCR (Enterovirus, HSV) Acid-fast bacillus (AFB) stain, fungal smear/culture, India ink

Why does CSF glucose drop in bacterial meningitis? Bacteria consume glucose for metabolic survival, but more importantly, inflammatory cytokines and damaged blood-brain barrier transport systems severely impair active, facilitated glucose transport across cerebral capillary endothelium into the CSF space.

  • 4. Infection Control, Empirical Antimicrobial Protocols & Chemoprophylaxis
  • Infection Control & Isolation Mandates

Droplet Precautions: All patients with suspected or confirmed bacterial meningitis must be immediately placed in a private room under Droplet Precautions (surgical mask worn within 3–6 feet of patient, eye protection if splashing anticipated).

Duration of Precautions: Droplet precautions must be maintained until the patient has completed at least 24 continuous hours of effective intravenous antimicrobial therapy that clears nasopharyngeal colonization (specifically applicable to Neisseria meningitidis and Haemophilus influenzae type b).

Empirical Intravenous Antibiotic Therapy

Antibiotics must never be delayed for imaging, diagnostic procedures, or bed placement:

Neonates (<28 Days):

IV Ampicillin (to cover Listeria monocytogenes and Group B Streptococcus) PLUS IV Gentamicin (aminoglycoside) OR IV Cefotaxime .

Caution

Neonatal Ceftriaxone Ban: Neonatal protocols generally avoid ceftriaxone. It is contraindicated in hyperbilirubinemic neonates and in neonates who require or are expected to require IV calcium-containing solutions; assess prematurity and the full product labeling. Ceftriaxone competitively displaces bilirubin from albumin-binding sites, causing severe unconjugated hyperbilirubinemia and life-threatening kernicterus (bilirubin encephalopathy). Additionally, ceftriaxone forms insoluble calcium precipitates in the gallbladder ("biliary sludging") and renal vasculature when administered concurrently with calcium-containing IV solutions.

Infants & Children (>1 Month to Adolescents):

IV Vancomycin (15 mg/kg IV q6h; to provide definitive coverage against penicillin- and cephalosporin-resistant Streptococcus pneumoniae ) PLUS IV Ceftriaxone (50 mg/kg IV q12h or 100 mg/kg q24h) OR IV Cefotaxime (third-generation cephalosporins providing high CSF bactericidal penetration against N. meningitidis , H. influenzae , and susceptible S. pneumoniae ).

Adjunctive Dexamethasone Protocol

Indication & Timing: Intravenous dexamethasone (0.15 mg/kg IV every 6 hours for 2 to 4 days) is recommended in infants and children ≥6 weeks of age with suspected or confirmed H. influenzae type b, and strongly considered in S. pneumoniae meningitis.

Critical Administration Rule: Dexamethasone must be administered prior to or concurrently with the very first dose of intravenous antibiotics . Administering dexamethasone blunts the massive inflammatory surge of TNF-alpha and IL-1 triggered when bactericidal antibiotics lyse bacterial cell walls. In clinical trials, early dexamethasone dramatically reduces the incidence of sensorineural hearing loss and long-term neurological sequelae. If antibiotics have already been running for hours, post-antibiotic steroids provide no documented neuroprotective benefit.

Close Contact Post-Exposure Chemoprophylaxis

Chemoprophylaxis eradicates nasopharyngeal carriage of Neisseria meningitidis in close contacts to prevent secondary transmission:

Definition of Close Contacts: Household members, daycare center contacts, roommates, anyone directly exposed to the index patient's oral secretions within 7 days prior to onset (e.g., mouth-to-mouth resuscitation, endotracheal intubation, or suctioning without wearing a surgical mask).

First-Line Chemoprophylaxis Regimens for Meningococcal Disease:

Oral Rifampin:

Children ≥1 month: 10 mg/kg PO every 12 hours for 4 doses (2 days) (max 600 mg/dose).

Neonates <1 month: 5 mg/kg PO every 12 hours for 4 doses .

Family Counseling: Warn patients and families that rifampin causes harmless, reversible red-orange discoloration of urine, saliva, sweat, tears , and will permanently stain soft contact lenses. It also induces cytochrome P450 enzymes, reducing the efficacy of oral contraceptive pills.

Intramuscular Ceftriaxone: Single IM dose (125 mg for children <15 years; 250 mg for adults/teens ≥15 years). Regimen of choice for pregnant close contacts and infants <1 month.

Oral Ciprofloxacin: Single oral dose (500 mg) for adults and older adolescents.

  • 5. Increased Intracranial Pressure (ICP) & The Monro-Kellie Hypothesis
  • The Monro-Kellie Doctrine

The cranial vault is a rigid, non-distensible bony structure with a fixed internal volume. Under normal physiological conditions, intracranial contents consist of three dynamic compartments:

Brain Tissue Parenchyma: ~80% of total intracranial volume.

Cerebrospinal Fluid (CSF): ~10% of total volume.

Intravascular Blood (Arterial and Venous): ~10% of total volume. Total Intracranial Volume = V(Brain) + V(CSF) + V(Blood) = CONSTANT

The Monro-Kellie hypothesis dictates that because the total volume is fixed, an increase in the volume of one compartment must be compensated by an equal, reciprocal reduction in the volume of another compartment to maintain normal intracranial pressure (ICP):

Compensatory Phase: When a mass lesion, cerebral edema, or ventricular fluid expands, the body compensates by displacing CSF downward into the distensible spinal subarachnoid space, accelerating CSF absorption at arachnoid granulations, and compressing low-pressure cerebral venous sinuses to shoo venous blood into the internal jugular veins.

Decompensation Phase: Once compensatory spatial displacement is exhausted, the compliance curve turns sharply vertical. Tiny subsequent increases in intracranial volume produce catastrophic, exponential spikes in ICP, collapsing cerebral perfusion pressure and driving brain tissue through internal cranial apertures ( cerebral herniation ). Normal Pediatric ICP: Infants: 1.5–6 mmHg | Children: 3–7 mmHg | Adolescents: 10–15 mmHg

  • Pathological Threshold: Sustained ICP > 20 mmHg requires aggressive therapeutic intervention
  • Clinical Manifestations of Increased ICP Across Ages

Age Group Early Clinical Manifestations Late Clinical Manifestations

Infants (Open Sutures & Fontanelles) Bulging, tense, non-pulsatile fontanelle; separated / widened cranial sutures; irritability; macrocephaly (accelerated head circumference growth); high-pitched cry; poor feeding "Setting-sun" sign (downward ocular deviation exposing white sclera above iris); distended scalp veins; Macewen's sign (cracked-pot resonance on skull percussion); profound lethargy, stupor

Children / Adolescents (Closed Sutures) Persistent morning headache that awakens child and worsens with Valsalva/coughing; morning vomiting without nausea (frequently projectile); diplopia; blurred vision; personality changes Papilledema (optic disc swelling with blurred margins); Abducens nerve (CN VI) palsy (inability to abduct eye laterally); ataxia; progressive stupor to coma; decorticate / decerebrate posturing

Why CN VI Palsy? The sixth cranial nerve (abducens) has the longest intracranial pathway along the base of the skull, making it exceptionally vulnerable to compression and traction when brain tissue shifts downward under high ICP.

Cushing's Triad: The Pre-Terminal Herniation Warning

Cushing's triad is a late, ominous physiological response to severe, life-threatening intracranial hypertension and brainstem compression (typically signifying transtentorial or tonsillar herniation). It is caused by severe ischemia of the medullary vasomotor center: CUSHING'S TRIAD (Pre-Herniation Signs):

  • 1. BRADYCARDIA (Marked drop in heart rate; baroreceptor-mediated vagal response)
  • 2. IRREGULAR, DEPRESSED RESPIRATIONS (Cheyne-Stokes breathing, central neurogenic hyperventilation, or apnea)

3. WIDENED PULSE PRESSURE WITH SYSTOLIC HYPERTENSION (Progressive increase in systolic BP with stable/falling diastolic BP)

The Hemodynamic Mechanism: When ICP exceeds mean arterial pressure, cerebral blood flow halts, causing profound ischemia of medullary neurons. The sympathetic nervous system mounts a massive adrenergic surge to force blood through cerebral capillaries, causing severe systolic hypertension. Carotid sinus and aortic arch baroreceptors detect this extreme hypertension and trigger intense parasympathetic (vagal) output to the heart, generating profound bradycardia. Concurrently, downward compression of the pontine and medullary respiratory control centers disrupts automated breathing rhythms.

6. Multimodal Nursing Management of Increased Intracranial Pressure

Managing increased ICP centers on optimizing Cerebral Perfusion Pressure (CPP) , defined mathematically as: CPP = MAP (Mean Arterial Pressure) - ICP

  • Pediatric Target CPP: Infants: 40–50 mmHg | Young Children: 50–60 mmHg | Older Adolescents: >60–70 mmHg
  • Evidence-Based Nursing Interventions Matrix for Increased ICP

Nursing Domain Specific Clinical Protocol Physiological Rationale & Safety Boundaries

Bed Positioning Elevate Head of Bed (HOB) 30 degrees ; maintain head, neck, and torso in strict neutral, midline alignment . Promotes gravity-assisted venous drainage through internal jugular veins. Avoid lateral head rotation, neck flexion, or hyperextension, which kink jugular veins and immediately spike ICP. Avoid hip flexion >90 degrees (which raises intra-abdominal and intrathoracic pressures).

Environmental Control Maintain a quiet, darkened room; limit visitors; speak in soft tones; dim monitoring alarms. Sudden loud noises or noxious stimulation provoke autonomic surges and acute spikes in ICP.

Cluster Care Precautions Do NOT cluster invasive nursing care . Space interventions (e.g., diaper changes, baths, line care) with adequate rest periods. Clustering multiple noxious interventions causes cumulative, prolonged ICP surges exceeding the safety threshold. Allow ICP to return to baseline between tasks.

Airway & Suctioning Suction only when clinically necessary; pre-oxygenate with 100% O2 ; limit suctioning to <10 seconds ; maintain gentle technique. Tracheal stimulation triggers intense coughing, Valsalva response, and dramatic ICP spikes. Consider pre-treatment with IV lidocaine to blunt the airway reflex.

Thermoregulation Maintain strict normothermia (core temp 36.5°C–37.5°C) ; administer antipyretics and employ cooling blankets promptly for fever. Hyperthermia accelerates Cerebral Metabolic Rate of Oxygen (CMRO2) by ~7% per 1°C increase, increasing cerebral blood volume and edema. Prevent shivering (shivering drastically spikes ICP and oxygen debt).

Respiratory Targets Maintain PaO2 >80–100 mmHg ; maintain PaCO2 within low-normal range (35–38 mmHg) . Hypoxemia causes potent cerebral vasodilation. Hypercapnia (elevated PaCO2) is the most potent cerebral vasodilator known; elevated PaCO2 rapidly expands intracranial blood volume. Avoid prolonged hyperventilation (<30 mmHg), which causes severe vasoconstriction and ischemic brain infarction.

Hyperosmolar Therapy Administer Hypertonic Saline (3% NaCl) 2–5 mL/kg IV bolus over 10–20 min; OR Mannitol (20%) 0.5–1.0 g/kg IV over 20–30 min. Creates an osmotic gradient across an intact blood-brain barrier, drawing water out of swollen parenchymal brain cells into intravascular circulation.

Fluid Administration Administer isotonic IV solutions (0.9% Normal Saline or Plasmalyte) at maintenance or slight fluid restriction (e.g., 80% to 100%). Strictly avoid hypotonic fluids (0.45% NS, D5W) ! Hypotonic fluids lower plasma serum osmolality, driving water across the blood-brain barrier into brain cells and catastrophically exacerbating cerebral edema.

Hyperosmolar Pharmacotherapy Monitoring

Hypertonic Saline (3% NaCl): Target serum sodium is typically 145 to 155 mEq/L ; target serum osmolality <360 mOsm/L. Serum sodium must be drawn every 4 to 6 hours. Central venous access is preferred to prevent peripheral vein phlebitis.

Mannitol (20%): Target serum osmolality is <320 mOsm/L (serum osmolality >320 mOsm/L induces acute renal tubular necrosis). An indwelling Foley catheter is mandatory to measure rapid osmotic diuresis and prevent bladder distension. Always inspect the vial for crystallization prior to administration; always use an in-line intravenous filter .